Results 51 to 60 of about 1,253,166 (338)
INTRODUCCIÓN: En 2019, surgió un nuevo coronavirus que causó una pandemia mundial. Durante 2020, se desarrollaron vacunas con aceptable seguridad y eficacia para disminuir complicaciones y muertes.
Lucas Fernando de Candia+15 more
doaj
Objective: We aimed to explore the dynamic changes in coagulation function and the effect of age on coagulation function in patients with pneumonia under admission and non-admission treatment.Methods: We included 178 confirmed adult inpatients with COVID-
Jiasheng Xu+17 more
doaj +1 more source
Coronavirus Update 5/14/2021: Congratulations on a Great Year [PDF]
We want to take a moment to congratulate the entire SHU community for an outstanding year keeping us on ...
The Coronavirus Planning Team,
core +1 more source
Coronavirus Update 2-10-22 [PDF]
The Connecticut Governor’s state-wide mask mandate for K-12 schools is set to expire at the end of this month, leaving the decision up to local communities.
The Coronavirus Planning Team,
core +1 more source
Coronavirus Update 9-2-21 [PDF]
We continue to have students, faculty and staff express concerns about members of the community who are either not wearing their masks indoors or are wearing them incorrectly.
The Coronavirus Planning Team,
core +3 more sources
Molecular stability of a vaccine strain of Canine coronavirus after serial passages in A72 cells
Canine coronavirus (CCoV) exists in types I and II and infects dogs leading mainly to enteritis, though type II has already been associated with generalized and highly lethal infection.
Iracema Nunes de Barros+3 more
doaj +1 more source
UPDATE Coronavirus Update 7-30-21 [PDF]
It has just been announced that the CDC is including Fairfield County as an area with substantial COVID-19 community transmission.
The Coronavirus Planning Team,
core +1 more source
Coronavirus Update 10-21-21 [PDF]
We hope you are as excited about Family Weekend as we are. The forecast is calling for crisp fall weather that will be perfect for the activities planned.
The Coronavirus Planning Team,
core +1 more source
Treatment process evolution. *The target TNC for BMH was ≥6 × 108/kg per patient. The Group B1 patient received lovo‐cel produced using both the original and refined manufacturing process, and the Group B2 patient received lovo‐cel produced using only the refined manufacturing process.
Julie Kanter+14 more
wiley +1 more source
Coronavirus Update 1-5-21 [PDF]
The country is currently experiencing increases in COVID-19 cases in most states, including a new strain that seems to spread even more easily than the previous one.
The Coronavirus Planning Team,
core +5 more sources